2025.03.04Information

NOTICE OF THE 26TH ANNUAL GENERAL MEETING OF SHAREHOLDERS

2025.02.19IR

FY2024 Financial Results Materials

2025.02.14IR

Notice of Recording of Non-operating Income, Non-operating Expenses, Extraordinary Income, Extraordinary Loss, Income Tax Adjustment and Difference between Consolidated Earnings Forecast and Actual Results for the Fiscal Year Ended December 31, 2024

2025.02.14IR

Consolidated Financial Report for the Fiscal Year 2024

2025.01.15IR

AnGes Initiates Sponsored Research Agreement with Stanford Medicine on the Development of Novel Genome-Edited Cancer Therapies

Learn more